Vermillion Return on Investment 2006-2019 | VRML

Current and historical return on investment (ROI) values for Vermillion (VRML) over the last 10 years.
Vermillion ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2019-06-30 $-0.01B $0.02B -143.59%
2019-03-31 $-0.01B $0.01B -140.54%
2018-12-31 $-0.01B $0.01B -137.14%
2018-09-30 $-0.01B $0.01B -150.00%
2018-06-30 $-0.01B $0.01B -157.14%
2018-03-31 $-0.01B $0.00B -190.48%
2017-12-31 $-0.01B $0.01B -153.85%
2017-09-30 $-0.01B $0.01B -153.85%
2017-06-30 $-0.01B $0.01B -162.96%
2017-03-31 $-0.01B $0.01B -162.50%
2016-12-31 $-0.02B $0.01B -162.16%
2016-09-30 $-0.02B $0.01B -212.50%
2016-06-30 $-0.02B $0.01B -165.22%
2016-03-31 $-0.02B $0.01B -228.57%
2015-12-31 $-0.02B -345.45%
2015-09-30 $-0.02B $0.02B -327.27%
2015-06-30 $-0.02B inf%
2015-03-31 $-0.02B inf%
2014-12-31 $-0.02B inf%
2014-09-30 $-0.02B inf%
2014-06-30 $-0.01B inf%
2014-03-31 $-0.01B inf%
2013-12-31 $-0.01B inf%
2013-09-30 $-0.01B inf%
2013-06-30 $-0.01B inf%
2013-03-31 $-0.01B inf%
2012-12-31 $-0.01B inf%
2012-09-30 $-0.01B inf%
2012-06-30 $-0.01B -280.00%
2012-03-31 $-0.02B -145.45%
2011-12-31 $-0.02B -98.63%
2011-09-30 $-0.02B $0.02B -89.41%
2011-06-30 $-0.02B $0.02B -94.74%
2011-03-31 $-0.02B $0.03B -123.08%
2010-12-31 $-0.02B $0.01B -260.87%
2008-12-31 $-0.02B -352.94%
2008-09-30 $-0.02B $0.00B -200.00%
2008-06-30 $-0.02B $0.01B -146.94%
2008-03-31 $-0.02B $0.01B -171.43%
2007-12-31 $-0.02B $0.02B -176.00%
2007-09-30 $-0.02B $0.02B -188.24%
2007-06-30 $-0.03B $0.01B -178.57%
2007-03-31 $-0.03B $0.01B -133.33%
2006-12-31 $-0.03B $0.02B -99.01%
2006-09-30 $-0.03B $0.02B -84.55%
2006-06-30 $-0.03B $0.03B -74.48%
2006-03-31 $-0.03B $0.03B -72.73%
2005-12-31 $-0.03B $0.04B -77.11%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.037B $0.003B
Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. Vermillion also intends to address clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others. Its lead product includes the OVA1 ovarian tumor triage test, which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. In addition to the OVA1 Test, Vermillion has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease. Vermillion, Inc. is based in Fremont, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $113.591B 24.20
Intuitive Surgical (ISRG) United States $59.705B 52.22
Edwards Lifesciences (EW) United States $47.232B 45.97
IDEXX Laboratories (IDXX) United States $23.830B 59.78
Fresenius Medical Care AG KGaA (FMS) Germany $20.090B 13.48
Olympus (OCPNY) Japan $18.383B 0.00
Teleflex (TFX) United States $14.891B 31.61
SONOVA HOLDING (SONVY) Switzerland $14.646B 0.00
DexCom (DXCM) United States $14.166B 209.93
Sysmex ADR (SSMXY) Japan $13.579B 36.55
Hologic (HOLX) United States $13.042B 20.59
STERIS (STE) Ireland $11.914B 27.48
Varian Medical Systems (VAR) United States $10.091B 24.14
Masimo (MASI) United States $7.756B 47.06
ABIOMED (ABMD) United States $7.698B 44.06
SARTORIUS AG (SARTF) Germany $5.614B 49.88
Integra LifeSciences Holdings (IART) United States $5.204B 23.22
Penumbra (PEN) United States $5.078B 182.43
Globus Medical (GMED) United States $5.001B 31.74
Elekta AB (EKTAY) Sweden $4.688B 36.09
LivaNova (LIVN) United Kingdom $3.431B 26.16
Tandem Diabetes Care (TNDM) United States $3.316B 0.00
Cantel Medical (CMD) United States $2.888B 29.17
Wright Medical Group (WMGI) Netherlands $2.584B 226.67
Nihon Kohden (NHNKY) Japan $2.578B 25.94
Nevro (NVRO) United States $2.519B 0.00
Integer Holdings (ITGR) United States $2.443B 17.28
Glaukos (GKOS) United States $2.246B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.886B 34.99
OPKO Health (OPK) United States $1.262B 0.00
Veracyte (VCYT) United States $1.226B 0.00
Inogen (INGN) United States $1.067B 26.17
Natus Medical (NTUS) United States $1.040B 24.23
ORTHOFIX MEDICAL INC (OFIX) United States $0.993B 31.19
Accelerate Diagnostics (AXDX) United States $0.981B 0.00
Mesa Laboratories (MLAB) United States $0.963B 40.04
Silk Road Medical (SILK) United States $0.958B 0.00
Luminex (LMNX) United States $0.896B 0.00
Corindus Vascular Robotics (CVRS) United States $0.889B 0.00
CryoLife (CRY) United States $0.872B 83.04
Tactile Systems Technology (TCMD) United States $0.848B 104.81
Pacific Biosciences Of California (PACB) United States $0.785B 0.00
Intersect ENT (XENT) United States $0.549B 0.00
AngioDynamics (ANGO) United States $0.546B 19.62
OrthoPediatrics (KIDS) United States $0.523B 0.00
Quotient (QTNT) Switzerland $0.487B 0.00
AxoGen (AXGN) United States $0.459B 0.00
Si-Bone (SIBN) United States $0.416B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.410B 15.75
GenMark Diagnostics (GNMK) United States $0.313B 0.00
Sientra (SIEN) United States $0.306B 0.00
Alphatec Holdings (ATEC) United States $0.303B 0.00
Fluidigm (FLDM) United States $0.299B 0.00
Semler Scientific (SMLR) United States $0.261B 43.96
IRadimed (IRMD) United States $0.246B 40.91
ViewRay (VRAY) United States $0.241B 0.00
Accuray (ARAY) United States $0.237B 0.00
CRH Medical (CRHM) Canada $0.220B 76.25
Stereotaxis (STXS) United States $0.215B 0.00
SeaSpine Holdings (SPNE) United States $0.204B 0.00
RTI Surgical (RTIX) United States $0.198B 29.78
Neuronetics (STIM) United States $0.164B 0.00
ConforMIS (CFMS) United States $0.152B 0.00
EDAP TMS S.A (EDAP) France $0.134B 66.00
T2 Biosystems (TTOO) United States $0.114B 0.00
Second Sight Medical Products (EYES) United States $0.100B 0.00
TransEnterix (TRXC) United States $0.098B 0.00
Sensus Healthcare (SRTS) United States $0.094B 0.00
Spectral Diagnostics (EDTXF) Canada $0.070B 0.00
Apollo Endosurgery (APEN) United States $0.058B 0.00
Electromed (ELMD) United States $0.055B 28.26
Helius Medical Technologies (HSDT) United States $0.040B 0.00
Ekso Bionics Holdings (EKSO) United States $0.039B 0.00
Bioanalytical Systems (BASI) United States $0.039B 0.00
Xtant Medical Holdings (XTNT) United States $0.036B 0.00
Nuvectra (NVTR) United States $0.026B 0.00
Neovasc (NVCN) Canada $0.025B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.025B 0.00
ReWalk Robotics (RWLK) Israel $0.021B 0.00
Restoration Robotics (HAIR) United States $0.017B 0.00
Ra Medical Systems (RMED) United States $0.016B 0.00
Cesca Therapeutics (KOOL) United States $0.016B 0.00
American Shared Hospital Services (AMS) United States $0.014B 20.24
Nanovibronix (NAOV) United States $0.013B 0.00
DarioHealth (DRIO) Israel $0.012B 0.00
Lianluo Smart (LLIT) China $0.011B 0.00
OBALON THERPTCS (OBLN) United States $0.009B 0.00
Dynatronics (DYNT) United States $0.008B 0.00
ENDRA Life Sciences (NDRA) United States $0.008B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.007B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Allied Healthcare Products (AHPI) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Avinger (AVGR) United States $0.005B 0.00
Sunshine Heart Inc (CHFS) United States $0.004B 0.00
InspireMD (NSPR) Israel $0.002B 0.00
Viveve Medical (VIVE) United States $0.002B 0.00